Zhejiang AngLiKang Pharmaceutical CO.,LTD. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 1,063.11 million compared to CNY 986.89 million a year ago. Revenue was CNY 1,063.11 million compared to CNY 986.89 million a year ago.

Net income was CNY 108.28 million compared to CNY 75.19 million a year ago. Basic earnings per share from continuing operations was CNY 0.547 compared to CNY 0.371 a year ago. Diluted earnings per share from continuing operations was CNY 0.547 compared to CNY 0.371 a year ago.